explore -WSS

explore

author：focus 2025-10-01 23:39:40 - browse：6

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： What is STAT's opinion section for?

WSS

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Chinese researcher claims birth of first gene

Study suggests Covid rebound is far more common with Paxlovid than without

Medicare Advantage insurers pressure Biden for bigger payments

White House drug czar issues call for 'recovery

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

knowledge

explore

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Novavax promises a turnaround & Lilly roils the obesity market

6 surprising facts about sugar

Peter Hotez and the public health issue of online harassment

What health policies could hitch a ride on a spending bill?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What is STAT's opinion section for?

After affirmative action ruling, medical educators look to 'holistic review'

CRISPR technology availability, affordability needs to be expanded

entertainment

Diabetes management: Digital health tools fall short, study says

What is STAT's opinion section for?

Readout Newsletter: Zepbound, Valneva's vaccine, and more

What health policies could hitch a ride on a spending bill?

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Pregnancy ages women, but effects reverse after delivery

explore

explore

entertainment

hotspot